Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Res…

Crown Bioscience (https://www.crownbio.com/), a global contract research organization (CRO) and JSR Life Sciences company, today announced the launch of its ground-breaking service offering, OrganoidXplore™. This large-scale organoid panel screening platform promises robust, reproducible, and clinically relevant output at record speed, accelerating preclinical oncology drug discovery by empowering researchers and reshaping the landscape of cancer treatment development. Screening of a large ...